Navigation Links
Compound from marine bacteria shows potential as multiple myeloma therapy

significant side effects in some myeloma patients, including altered blood counts and nerve pain. In some patients, the disease can be resistant or become resistant to bortezomib.

Because NPI-0052 and bortezomib attack the same intracellular target in different ways, the Dana-Farber researchers contend that combining these two agents might be more effective than using either therapy alone ?and be better tolerated by patients as well.

In preclinical studies, NPI-0052 blocks a wider range of proteasome activities than bortezomib, say the researchers, and works at lower doses. NPI-0052 also appears to be less toxic to normal cells. Bortezomib is currently given by intravenous infusion. "NPI-0052 can be given orally, although the first clinical trials will be using the intravenous route," says Paul Richardson, M.D, who is also a co-author in this study and will be leading the Phase-I clinical trial in myeloma at Dana-Farber.

NPI-0052 was discovered by William Fenical, PhD, and his collaborators at The Scripps Institute of Oceanography during the fermentation of Salinispora, a new class of marine gram-positive bacteria identified in sediment samples from the ocean floor. The substance has shown strong anticancer properties in laboratory tests. Nereus Pharmaceuticals holds an exclusive license to the compound for drug development.

Experiments with NPI-0052 began at Dana-Farber in 2003, said Dharminder Chauhan, PhD, lead author of the paper along with Laurence Catley, PhD. When added to cells from patients whose disease was resistant to both standard drugs and bortezomib, the compound efficiently killed the cells. Analyses showed that NPI-0052 and bortezomib express different profiles for inhibiting the three major proteasome activities.

In mice implanted with human myeloma tumor cells, NPI-0052 was well tolerated, prolonged survival and significantly reduced the rate of cancer recurrences. Because NPI-0052 and bortezomib bloc
'"/>

Source:Dana-Farber Cancer Institute


Page: 1 2 3

Related biology news :

1. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
2. Newly Discovered Compound Blocks Known Cancer-Causing Protein
3. Compounds in plastic packaging act as environmental estrogens altering breast genes
4. Compound might defeat African sleeping sickness, clinical trial beginning this month
5. Compound from Chinese medicine shows promise in head and neck cancer
6. Anti-cancer Compound In Beer Gaining Interest
7. Compound in dairy products targets diabetes
8. Compound eyes, evolutionary ties
9. Sequencing of marine bacterium will help study of cell communication
10. Solutions that reduce death of marine life reeled in by International Smart Gear Competition
11. UN environmental agency steps up battle against marine pollution

Post Your Comments:
(Date:11/20/2009)... Toxic dust: Toxins in coal-tar-based sealcoats ... house dust, according to a USGS study. PAHs or ...les found in oil, coal and tar deposits, and can h...are often found in house dust; however, the specif... Researchers found that dust from indoor areas nea...
(Date:11/20/2009)...s release is available in German . , In the...Investigation , Dr. Stefanie Eyerich and Dr. Kilia...rial College London and Istituto Dermopatico dell,...iscovery. It represents a milestone on the way to ...skin diseases such as psoriasis and allergic react...
(Date:11/20/2009)...gh University,s Energy Research Center (ERC) has b...ergy (DOE) to develop methods of recovering and re...on-dioxide (CO 2 ) compression process in a carbon...is to facilitate carbon capture and sequestration,... 2 , a greenhouse gas, emitted into the atmosphere...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Discovery of new type of immune cells regulating inflammation in chronic diseases 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 1Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 2Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 3Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 4Funxional Successfully Completes Initial Clinical Trial of FX125L an Anti Inflammatory Drug With a Novel Mechanism of Action 12935 1Funxional Successfully Completes Initial Clinical Trial of FX125L an Anti Inflammatory Drug With a Novel Mechanism of Action 12935 2Meatless Burgers Hot Dogs Not Always Full of Veggies 51049 1Meatless Burgers Hot Dogs Not Always Full of Veggies 51049 2
...in the Health Care Industry, SAN JOSE, Calif., No...NUF), a leading biometric and security solutions,p...ith Hong Kong,Polytechnic University Clinic for th...red by Titanium,s Biometric Facial Recognition tec...atients, together with their,corresponding medical...
...ed Nations Climate Change Conference in Bali, Indo...tion and the critical role that remote sensing sys... Emissions from Deforestation and Degradation) mec...t nations for avoiding deforestation. Using synthe...week period by the Japanese Advanced Land Observin...
...stin has received $1.9 million to expand a compute...isions about placement of devices to detect nuclea...meland Security provided the funds to improve the ...in Russia and other countries of the former Soviet...tores of nuclear weapons material and radioactive ...
Other Biology News:Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 2Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 3Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 2Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 3Improving detection of nuclear smuggling goal of computer model of mechanical engineer 2Improving detection of nuclear smuggling goal of computer model of mechanical engineer 3
(Date:11/19/2009)...ER, Germany, November 19 MONITORIN...ember 16th, 2009 Flibanserin in the,indication tre...kinson,s,disease for orphan drug status designatio...opa-induced dyskinesia is a complication of the ma...ious burden to some of those,affected, since it ma...
(Date:11/19/2009)...NA, Austria, November 19 AFFiRiS A...e product candidate at an unexpectedly early,stage...nned to enter into,Phase II clinical trial early i...ollows the completion of two Phase I trials with t... fast decision on the first interim,analysis of th...
(Date:11/18/2009)... University Belfast are developing new sensors to ...l help in the fight against the threat of terroris...ds to ,swipe, an individual or crime scene to gath...nstrument that can detect the presence of chemical...ecisions to be made in response to terrorist threa...
(Date:11/18/2009)...K, Nov. 18 Reportlinker.com announ... in its catalogue. ,, Biotechnology Reagents ....reportlinker.com/p0164375/Biotechnology-Reagents-...wswire&utm_medium=pr&utm_campaign=prnewswi...lex chemical compounds used in a range of biotech ...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8
...f, cells from pigs are to be used in clinical tria...betes, MINNEAPOLIS, July 29 The Lions Clubs of M...ommitment to support Spring Point,Project, a Minne...he,affordable and widespread availability of pig d... http://www.newscom.com/cgi-bin/prnh/20071214/CLF0...
...ar Equity, LLC issues a review of,VioQuest Pharmac..., "510k,Application Submitted for Xyfid(TM) and Pr...stones and Share Price Appreciation.", This revie...ity.com ., VioQuest Pharmaceuticals is a New Jers...ng a recognized leader in the successful developme...
...29 Zenobia Therapeutics, Inc.,(Zenobia) announced...ment,Initiative award from The Michael J. Fox Foun...ts industry-based research with potential to,funda...PD) treatment. In,collaboration with Dr. Christoph...iscover and develop compounds that block the activ...
Other Biology Technology:Spring Point Project Gains Support of Lions Clubs 2Spring Point Project Gains Support of Lions Clubs 3VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC 2Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinson's Research Award for Work on PD-implicated Protein LRRK2 2
... positive control for ChIP assays. Efficient fixat... step for the Chromatin-immunoprecipitation (ChIP)... the most important parameter. Two major problems ... should be taken into account: first, an excess of...
Mouse Anti-MRP2 Monoclonal Antibody, Unconjugated, Clone M2II-12 from Abcam
MS 5000HV Power Supply from Major Science
Chicken Anti-Rab GDP dissociation inhibitor beta Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Biology Products: